Longhorn is developing novel, broad based, healthcare-changing solutions to better diagnose, prevent, and treat diseases. Ranging from viral and bacterial infections to inflammatory diseases such as Alzheimer’s and Parkinson’s, Longhorn’s portfolio has the potential to impact lives in the US and around the World.
Cambridge Biologics is a leading provider of biological reagents.
Paraza Pharma is a fully integrated R&D organization providing a full suite of discovery services, with extensive expertise across our Chemistry, Biology and DMPK functions.
Vega BioImaging is transforming cancer diagnostics with the first quantitative multi-protein imaging platform, combining nanotechnology and artificial intelligence.
Prime Bio’s research team consists of experienced scientists trained from cell biology, molecular biology, protein chemistry, molecular imaging and many other fields, and can perform any research projects related to botulinum neurotoxin including assay development, cellular binding and translocation study, molecular imaging and many others.
PharmAla Biotech is a Canadian biotechnology company dedicated to the domestic research & development and sourcing of clinical-grade LaNeo™ MDMA and novel MDXX compounds in service to the scientific research community and commercial use in select jurisdictions.
Discovery Biotech is a clinical stage biotech company that transforms scientific discoveries into impactful medical solutions.
Capsigen is engineering novel AAV capsids to address difficult-to-treat diseases.
Skroot is launching SMART line products for glass and plastic culture ware that make any vessel smart.
Optics11 Life offers precise mechanobiology & contractility assay platforms for advancing biomarker discovery in translational research.
Rubhu Biologics is committed to providing state of the art services for the discovery and development of novel bio-therapeutics.
Nextnet is the life sciences AI platform where researchers love researching. Featuring Copilot research assistants and Connected Search.
Evolved Analytics offers a complete portfolio of consulting, project design, execution and training that complements unique do-it-yourself software suites that continue to outperform other augmented analytics, artificial intelligence (AI) and machine learning platforms.
Tissue Testing Technologies provides contract research and distribute chemically designed solutions for bio-preservation of living materials. Their core competences are bio preservation of living materials and bio assays to determine whether the cells and tissues are still functional after experimental treatments or in vivo transplantation.
Stately Bio is developing the next generation of life-saving regenerative medicines with the world’s most advanced ML cell imaging platform.
VirtuOx, a Resmed company, is a healthcare information technology company that provides diagnostic tools and services that enable a variety of healthcare organizations and professionals to diagnose and treat diseases through vertically integrated platforms, products and services.
VirtuOx, a Resmed company, is a healthcare information technology company that provides diagnostic tools and services that enable a variety of healthcare organizations and professionals to diagnose and treat diseases through vertically integrated platforms, products and services.
VirtuOx, a Resmed company, is a healthcare information technology company that provides diagnostic tools and services that enable a variety of healthcare organizations and professionals to diagnose and treat diseases through vertically integrated platforms, products and services.
Genesis Drug Discovery & Development is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery and development.
Creyon Bio is a nucleic acid drug development company whose goal is to make oligonucleotide (oligo) therapies safer and more effective for patients with rare and common diseases.
Creyon Bio is a nucleic acid drug development company whose goal is to make oligonucleotide (oligo) therapies safer and more effective for patients with rare and common diseases.
Vantive, formerly Baxter Kidney Care, is a vital organ therapy company on a mission to extend lives and expand possibilities for patients and care teams everywhere.
Ardena is a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical Contract Research Organization (CRO) in precision medicine development of new, innovative, and complex molecules.
Potato enables high-quality science by providing repeatable, well-defined protocols and software pipelines, building a future where AI can help humans find and understand reference literature, and optimize protocol steps based on published methods. From there, it’s a short jump to an AI research assistant. With the help of AI, a single scientist will be able…
BioSymetrics, a Renovaro company, is a leading AI-powered drug discovery and data analytics company, focusing on phenotype-based insights to identify novel therapeutics. Its proprietary Elion platform integrates large-scale biological and clinical data to drive innovation in the pharmaceutical and healthcare industries.
Decycle Biosystems is developing novel biochemical pathways that convert waste to value and help decarbonize the chemicals industry. By leveraging the latest tools in computational pathway prediction and enzyme modeling combined with cell-free synthesis, they seek to usher in a new era of industrial biotechnology.
Pathline®, a NeoGenomics company, is a full-service anatomic pathology company providing diagnostic and consulting services to healthcare organizations across the continuum of care.
MatTek is a leader in reliable in vitro human tissue model innovation. Their skin, ocular, oral, respiratory, and intestinal tissue models are used to assess safety and efficacy throughout the cosmetics, chemical, pharmaceutical, and household product industries.
Lena Biosciences engineers fit-for-purpose 3D tissue models and assays for drug discovery and predictive toxicology.
The Neural Stem Cell Institute (NSCI) and the Regenerative Research Foundation, the first independent stem cell research institute in the country, for the successful translation of neural stem cell discoveries to therapeutics. Rooted in academic research and administratively lean, NSCI can rapidly and effectively advance discoveries out of the research lab towards the clinic.